SBI Executes Seven Transactions Devoted to Lower-Limb Technologies

April 1, 2007

3 Min Read
SBI Executes Seven Transactions Devoted to Lower-Limb Technologies

In March, Small Bone Innovations Inc. (SBI; New York City), a medical device manufacturer that focuses exclusively on orthopedic care related to small bones and joints, announced seven acquisitions and licensing agreements dedicated to its portfolio of technologies related to the lower limb.

SBI was founded in 2004 by Viscogliosi Bros. LLC (New York City), a merchant banking firm that specializes in the musculoskeletal and orthopedic sector. In establishing SBI, Viscogliosi Bros. acquired several U.S., Canadian, and European orthopedic device companies and product technology licenses focused on small bone and joint treatment, including arthroplasty, internal and external fixation, trauma, and tissue technology. Since then, the company has grown significantly through additional acquisitions and licensing agreements. During 2006, the company devoted much of its acquisition activity and development to technologies focused on upper limbs.

Marking a shift in focus for 2007, the seven recent lower-limb transactions are as follows.

  • SBI purchased a full suite of fixation devices for small bone reconstruction and repair from Euromedic International Group. The company reports that the products have broad applications in the foot and ankle, as well as the hand and arm. They are currently available only outside of the United States, and SBI plans to bring them into the United States upon completion of what the company hopes will be a rapid regulatory clearance process. The acquired suite also includes a number of prepatent intellectual property filings to expand SBI's lower-limb internal fixation product portfolio. Additionally, key members of the Euromedic team have joined SBI.

  • SBI acquired significant intellectual property related to a metatarsal implant designed for surgical replacement or resurfacing of the first metatarsophalangeal (MTP) joint. The implant was designed and developed by Shane M. Hollawell, DPM.

  • SBI acquired significant intellectual property and related assets for the Trihedron MTP hemi implant, designed and developed by Charles Sorbie, MB, ChB, and Gerald Saunders. SBI reports that the implant is uniquely designed with an anatomically shaped stem that complements the SBI SR arthroplasty product line. The device has received 510(k) clearance to be marketed in the United States, and it is also approved in Canada.

  • SBI has entered into a licensing agreement for the Roto-glide three-part anatomical great toe system, designed and developed by Hakon Kofoed, MD, and Implants International (Cleveland, England).

  • SBI has entered into a licensing agreement for a unique ankle distraction system using external fixation. The system was designed and developed by S. Robert Rozbruch, MD, director of the Institute for Limb Lengthening and Reconstruction (New York City).

  • SBI is also licensing a variable-angle, multidimensional locking titanium plate and screw systems technology that was designed and developed by D. F. Wolter and Litos GmbH & Co. KG (Hamburg, Germany). SBI has licensed worldwide rights (with the exception of Germany) for use in the upper limbs, as well as for applications in the ankle, tibia, and fibula of the lower limbs. The company reports that it plans to introduce a variety of products using the technology over the next six to 12 months.

  • Through a licensing agreement with Therics LLC (Akron, OH), SBI also announced the release of its small-bone void filler product line.

Shortly after announcing the transactions—financial details of which were not disclosed—SBI reported that it has secured a $20 million debt facility. The debt financing was provided by Drawbridge Special Opportunities Fund, a fund managed by an affiliate of Fortress Investment Group (New York City).

© 2007 Canon Communications LLC

Return to MX: Issues Update.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like